Health Promotion and Management for Hepatitis B Carriers

National Taiwan University

Status

Unknown

Conditions

Chronic Hepatitis B

Treatments

Behavioral: standardized exercise program and dietary counseling

Study type

Interventional

Funder types

Other

Identifiers

NCT01065363

200906036R

Details and patient eligibility

About

The investigators propose a project of preventive medicine with concern of local context in Taiwan. The target population includes all staff and faculty members, students, and alumni of a university in Northern Taiwan, with chronic hepatitis B infection. The intervention of this project includes standardized lectures, sports courses, nutrition courses, and an information platform. The investigators will evaluate the efficacy after the intervention, like the reduction of hepatitis B viral load and the associated anthropometric parameters. The results of this project will be initially served as a pilot study for this cohort, and applicated as a promising basis for health promotion.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Participants were recruited from students, alumni, faculty and staff members with chronic HBV infection (positive HBsAg serostatus ≥6 months) in a university of northern Taiwan from August 1, 2009 to July 01, 2010. Only participants aged 18 and older were included.

Exclusion criteria

Excluded were:
- (a) those who had been diagnosed as chronic liver diseases like chronic hepatitis C infection (Anti-HCV (+)), autoimmune hepatitis, Wilson disease, alcoholic liver diseases, drug-related hepatitis, decompensated liver diseases, cirrhosis, or malignant hepatic tumors;
(b) those who had undergone liver transplantation or major operations for liver except cholecystectomy;
(c) men who consumed more than 30 gram of alcohol per week or women who consumed more than 20 gram of alcohol per week;
(d) women who were pregnant;
(e) those who had current medications for any types of chronic diseases except for hyperglycemia, elevated blood pressure, or dyslipidemia within six months.